Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Artiva

Artiva is a biotechnology company that develops and commercializes cell-based therapies for the treatment of hematologic cancer. Read more

Artiva

Artiva is a biotechnology company that develops and commercializes cell-based therapies for the treatment of hematologic cancer. Read more

Fred Aslan's photo - President & CEO of Artiva

President & CEO

Fred Aslan

CEO Approval Rating

90/100

Founded:

2019

Status:

PrivateIndependent Company

Website:

Est. Annual Revenue
Est. Employees
Sector
Biotechnology
Headquarters

ARTIVA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Artiva's top 5 competitors are Nkarta, NantKwest, Catamaran Bio, Fate and Dragonfly. Together they have raised over 978.9M between their estimated 629 employees. Artiva's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 7.4M. Artiva has 48 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 82.

Nkarta is Artiva's top competitor. Nkarta was founded in 2015 in South San Francisco, California. Nkarta competes in the Biotechnology field. Nkarta generates $2.9M less revenue than Artiva.

NantKwest is perceived as one of Artiva's biggest rivals. NantKwest's headquarters is in Culver City, California, and was founded in 2002. Like Artiva, NantKwest also competes in the Biotechnology industry. NantKwest generates 3.70% of Artiva's revenue.

Catamaran Bio is one of Artiva's top competitors. Catamaran Bio is a Private company that was founded in Cambridge, Massachusetts in 2020. Like Artiva, Catamaran Bio also competes in the Biotechnology field. Catamaran Bio has 25 fewer employees vs. Artiva.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Artiva?

I don't know

Artiva Acquisitions

No recent acquisitions found related to Artiva

Artiva Funding History

$0$78M$198M

Since Artiva was founded in 2019, it has participated in 3 rounds of funding. In total Artiva has raised $198.0M. Artiva's last funding round was on Feb 2021 for a total of $120.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Feb 2021
$120M

Venrock Healthcare Capital Partners

Series A
Jun 2020
$78M
Seed
Aug 2019
--

Total Funding: $198M

Since Artiva was founded in 2019, it has participated in 3 rounds of funding. In total Artiva has raised $198.0M. Artiva's last funding round was on Feb 2021 for a total of $120.0M

Artiva Investments

No recent investments found related to Artiva

Artiva News

January 28, 2021The Pharma Letter

Artiva inks landmark $1. 8 billion collab with Merck

San Diego, USA-based biotech Artiva Biotherapeutics has entered into a worldwide collaboration and li... See more »
July 19, 2020Pharamceutical Technology

Artiva closes $78m Series A round

San Diego-based, oncology-focused Artiva Biotherapeutics has closed its Series A financing round with... See more »
July 13, 2020San Diego Business Journal

Industry Veterans Start New Company, Raise $78M For Cell-Based Cancer Therapies

BIOTECH: Artiva Biotherapeutics to Start Clinical Trials This Year... See more »
June 30, 2020VC News Daily

Artiva Biotherapeutics Closes $78M in Series A

SAN DIEGO, CA, Artiva Biotherapeutics announced that it has launched and closed $78 million in Series... See more »
June 30, 2020Pulse2.0

Allogeneic Natural Killer Cell Therapy Company Artiva Biotherapeutics Raises $78 Million

Artiva Biotherapeutics, an oncology company focused on developing and commercializing allogeneic natu... See more »
June 26, 2020The San Diego Union Tribune

Biotech raises $78M to unleash immune system's natural killers against cancer

Artiva Biotherapeutics expects to begin clinical trials by year's end... See more »
June 26, 2020Xconomy

Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies

Creating cell therapies for cancer is a complex process. The business case for them has proven tricky... See more »

Artiva Press Releases

November 5, 2020GlobeNewswire

Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies

See more »

Social Media

Artiva Headquarters

4747 Executive Drive Suite 1150

San Diego, California92121

858-267-4467

Driving Directions »

Trending Companies

Artiva Summary

ABOUT

Overview

Artiva is a biotechnology company that develops and commercializes cell-based therapies for the treatment of hematologic cancer. Artiva was founded in 2019. Artiva's headquarters is located in San Diego, California, USA 92121. It has raised 198.0M in ...

CEO

Artiva's President & CEO, Fred Aslan, currently has an approval rating of 90%. Artiva's primary competitors are Nkarta, NantKwest & Catamaran Bio.

Website

artivabio.com

Frequently Asked Questions about Artiva

  1. When was Artiva founded?

    Artiva was founded in 2019

  2. Who is Artiva's CEO?

    Artiva's CEO is Fred Aslan

  3. How much revenue does Artiva generate?

    Artiva generates $3M in revenue

  4. How much funding does Artiva have?

    Artiva has historically raised $198M in funding

  1. Where is Artiva's headquarters?

    Artiva's headquarters is in San Diego California, USA

  2. How many employees does Artiva have?

    Artiva has 48 employees

  3. What sector does Artiva operate in?

    Artiva is in Biotechnology

  4. Who are Artiva's competitors?

    Artiva's top competitors are Nkarta, NantKwest, Catamaran Bio
Stay up-to-date with the latest news on Artiva

© 2021 Owler, Inc.